APA (7th ed.) Citation

Pham, T. D., Becker, J. H., Metropulos, A. E., Mubin, N., Spaulding, C., Bentrem, D. J., & Munshi, H. G. Regorafenib induces DNA damage and enhances PARP inhibitor efficacy in pancreatic ductal carcinoma. BMC.

Chicago Style (17th ed.) Citation

Pham, Thao D., Jeffrey H. Becker, Anastasia E. Metropulos, Nida Mubin, Christina Spaulding, David J. Bentrem, and Hidayatullah G. Munshi. Regorafenib Induces DNA Damage and Enhances PARP Inhibitor Efficacy in Pancreatic Ductal Carcinoma. BMC.

MLA (9th ed.) Citation

Pham, Thao D., et al. Regorafenib Induces DNA Damage and Enhances PARP Inhibitor Efficacy in Pancreatic Ductal Carcinoma. BMC.